Ultrasound vs. touch: which gets the IV right the first time?

NCT ID NCT07798427

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 01, 2026 · Last updated Sep 02, 2026 · Updated 1 time

Summary

This trial tests whether using ultrasound to guide IV placement helps get the needle in on the first attempt, compared with the traditional method of feeling and looking for a vein. Adults and teens who need an IV as part of their care may join. Researchers will measure first-attempt success, number of attempts, time to success, pain, and complications. The goal is to see if ultrasound makes IV insertion easier and less painful.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ultrasound-guided peripheral vascular access (a procedure using ultrasound imaging to guide IV catheter placement)
What this could lead to
If ultrasound guidance improves first-attempt success, it could reduce repeated needle sticks, pain, and complications for patients needing IVs, and may become a standard practice.
What could go wrong
The trial is early and results may not show a clear benefit. Ultrasound requires training and equipment, and its advantage may vary by patient and operator experience.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 250 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Mar 2030

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 12 years or older. * Requires peripheral venous vascular access as part of clinically indicated care. * Considered medically appropriate for peripheral intravenous catheter placement. * Able to undergo either ultrasound-guided or standard peripheral vascular-access procedures according to the study protocol. * For participants age 18 years or older, able to provide informed consent or participate under another IRB-approved consent process. * For participants younger than 18 years, permission from a parent or legally authorized representative and participant assent will be obtained when required by the reviewing IRB and applicable regulations. * Vascular access is expected to be performed at an anatomical site suitable for peripheral venous catheterization. * Participants with or without difficult intravenous access may be enrolled. * Willing and able to complete protocol-required procedural assessments and follow-up when applicable. Exclusion Criteria: * Immediate life-threatening or emergency circumstances in which study enrollment, consent, assent, parental permission, or randomization could delay medically necessary treatment. * Existing functional vascular access that eliminates the clinical need for a new peripheral intravenous catheter. * Clinical requirement for immediate central venous, intraosseous, midline, PICC, or other non-peripheral vascular access rather than peripheral cannulation. * Infection, significant burn injury, major trauma, vascular injury, or another condition at the proposed access site that makes peripheral cannulation inappropriate. * Known vascular abnormality or another clinical condition that, in the judgment of the treating clinician or investigator, makes either randomized vascular-access strategy inappropriate or unsafe. * Inability to undergo either study-assigned vascular-access approach. * For participants younger than 18 years, inability to satisfy applicable parental permission and assent requirements unless an IRB-approved exception applies. * Participation in another interventional study that, in the investigator's judgment, could materially interfere with assessment of vascular-access outcomes. * Any medical, procedural, or logistical circumstance in which participation could interfere with timely delivery of clinically necessary care.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Catheterization, peripheral are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Truway Health, Inc.

    New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.